Kewaunee Scientific Corporation KEQU Finance Lease, Principal Payments

Finance Lease, Principal Payments at other companies

Ginkgo BioworksDNA

——

Lifetime BrandsLCUT

——

Rapid Micro BiosystemsRPID

——

West Pharmaceutical ServicesWST

——

Other financials

Income statement

See full

Revenue$71.4M-7.5%

Gross profit$21.2M-11.6%

Operating income$5.2M-38.6%

Net income$3.4M-30.1%

EPS (diluted)$1.13-30.7%

Balance sheet

See full

Cash & equivalents$10.0M-42.0%

Total debt$25.3M+6.6%

Total equity$74.7M+15.9%

Total assets$178.3M-8.4%

Cash flow

See full

Operating cash flow$5.5M-42.0%

CapEx$928.0K+79.8%

Free cash flow$4.5M-49.0%

Valuation

See full

Market cap$101.96M-34.8%

Enterprise value$117.3M-28.0%

P/E10.6×-3.1×

P/S0.4×-0.3×

Profitability

See full

Gross margin28.5%-0.1pp

Operating margin5.9%-1.5pp

Net margin3.4%-1.3pp

FCF margin5.2%—

Returns & leverage

See full

Return on equity13.8%-5.3pp

Debt / equity0.3×0.0×

Current ratio2.2×0.0×

Where this comes from

Reported directly by Kewaunee Scientific Corporation in its filing.

Tagged under the XBRL concept us-gaap:FinanceLeasePrincipalPayments.

The official record: Kewaunee Scientific Corporation’s 10-K, filed June 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kewaunee Scientific Corporation's finance lease, principal payments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Kewaunee Scientific Corporation's finance lease, principal payments?: Kewaunee Scientific Corporation (KEQU) reported finance lease, principal payments of $16K in Q1 2026.
How has Kewaunee Scientific Corporation's finance lease, principal payments changed year-over-year?: Kewaunee Scientific Corporation's finance lease, principal payments increased by 128.6% year-over-year, from $7K to $16K.